Delivery Order SPE2DR25D3013-SPE2DR26F6U2J
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Azathioprine 50 mg tablets (100-count units) with a ceiling value of $3,311.13. This contract employs firm fixed-price pricing and is scheduled for ultimate completion by December 8, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units. This non-set-aside, firm fixed-price delivery order has a ceiling value of $3,177.01 and is scheduled for completion by December 10, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.77 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units). This competitive contract award, finalized on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. The performance location is identified as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $1,055.10 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100 count) on December 4, 2025, with completion scheduled for December 5, 2025. This non-competitive, firm fixed-price delivery order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100 count) under a firm fixed-price contract type with no set-aside designation. The award, issued on December 8, 2025, carries a ceiling value of $5,064.48 and an ultimate completion date of December 9, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.08 to AmerisourceBergen Drug Corp for 100 tablets of Azathioprine 50 mg. This competitive, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by December 2, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units. This contract, valued at $3,126.34 with a firm fixed price structure, represents a non-set-aside competitive award and is scheduled for completion by December 8, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $5,143.07 to AmerisourceBergen Drug Corp for the supply of Azathioprine 100 mg tablets (100 count). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order was placed on December 11, 2025, with an ultimate completion date of December 12, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) under a firm fixed price contract valued at $2,091.28. This non-set-aside, competitively awarded delivery order is scheduled for completion by December 5, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $5,064.48. The delivery order, which is non-set-aside and competitively awarded, has an ultimate completion date of December 5, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F6U2JDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for azathioprine 50 mg tablets (100-count packages) with a ceiling value of $1,069.53. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on December 9, 2025, with an ultimate completion date of December 10, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime vehicle designated SPE2DX and running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for Defense Health Agency and military healthcare systems. As a prime contractor under the DLA's pharmaceutical supply chain, the company demonstrates significant capability in fulfilling diverse federal medical supply requirements through open competition. The company's portfolio encompasses an extensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, positioning it as a key supplier within the federal medical supply infrastructure supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/8/25 |